Landos Biopharma Inc (LABP)
22.46
+0.16
(+0.72%)
USD |
NASDAQ |
May 17, 16:00
22.46
0.00 (0.00%)
After-Hours: 17:53
Landos Biopharma Cash and Short Term Investments (Quarterly): 29.00M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.00M |
| December 31, 2023 | 37.50M |
| September 30, 2023 | 42.47M |
| June 30, 2023 | 44.74M |
| March 31, 2023 | 50.01M |
| December 31, 2022 | 44.40M |
| September 30, 2022 | 47.99M |
| June 30, 2022 | 55.75M |
| Date | Value |
|---|---|
| March 31, 2022 | 73.80M |
| December 31, 2021 | 90.88M |
| September 30, 2021 | 102.67M |
| June 30, 2021 | 115.13M |
| March 31, 2021 | 106.36M |
| December 31, 2020 | 28.13M |
| September 30, 2020 | 35.33M |
| December 31, 2019 | 49.96M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
28.13M
Minimum
Dec 2020
115.13M
Maximum
Jun 2021
59.63M
Average
48.98M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie Inc | 18.07B |
| Fusion Pharmaceuticals Inc | 210.52M |
| Masimo Corp | 149.50M |
| Kinnate Biopharma Inc (DELISTED) | 154.03M |
| Invivyd Inc | 189.39M |